This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
biofuels: Archive
ACADIA (ACAD) Q2 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
ACADIA's (ACAD) loss narrows in the second quarter of 2021 while its revenues miss the mark. The company has reduced its revenue guidance for 2021. Shares down in after-hours trading.
TECHNegative Net Change ACADPositive Net Change SPRONegative Net Change COCPPositive Net Change
biofuels earnings
Editas (EDIT) Q2 Earnings Beat Estimates, Revenues Fall Y/Y
by Zacks Equity Research
Editas (EDIT) reports narrower-than-expected loss in the second quarter of 2021 while revenues miss estimates. Focus remains on the development of CRISPR gene-editing candidate, EDIT-101.
ABBVNegative Net Change TECHNegative Net Change EDITNegative Net Change SPRONegative Net Change
biofuels earnings
Kinder Morgan (KMI) Boosts Green Portfolio Via Kinetrex Buyout
by Zacks Equity Research
Kinder Morgan (KMI) expects the $310 million Kinetrex Energy acquisition to close in the third quarter of this year.
MMPPositive Net Change MURNegative Net Change KMIPositive Net Change CQPNegative Net Change
alt-energy biofuels energy esg oil-energy
TotalEnergies (TTE), Veolia to Develop Microalgae for Biofuels
by Zacks Equity Research
TotalEnergies (TTE) partners with Veolia to develop microalgae, which will ultimately assist the company in biofuel production. It strives to be a net-zero carbon emission company by 2050.
CVXPositive Net Change RDS.APositive Net Change TTENegative Net Change
alt-energy biofuels oil-energy
5 Stocks With Upbeat Sales Growth Worth Betting on Right Now
by Swayta Shah
Sales growth is crucial for the survival of any business. Let's check out CarMax (KMX), Crown Holdings (CCK), CenterPoint Energy (CNP), Nutrien (NTR) and Xylem (XYL) that are likely to record robust sales growth.
CNPNegative Net Change CCKNegative Net Change KMXNegative Net Change XYLNegative Net Change NTRNegative Net Change
agriculture auto-tires-trucks biofuels energy finance industrial-products oil-energy utilities
Eni's (E) Versalis & Saipem to Produce Advanced Biofuel
by Zacks Equity Research
The latest deal signed by Eni's (E) chemical company Versalis can play a huge role in the overall decarbonization program of the former.
ENegative Net Change PHXPositive Net Change SAPMFNegative Net Change EQNRNo Net Change
alt-energy biofuels energy oil-energy
How Aemetis (AMTX) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Aemetis (AMTX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
AMTXNegative Net Change
biofuels energy oil-energy
Zacks Industry Outlook Highlights: Moderna, Amgen, BioNTech, Repligen Corp and Ovid Therapeutics
by Zacks Equity Research
Zacks Industry Outlook Highlights: Moderna, Amgen, BioNTech, Repligen Corp and Ovid Therapeutics
MRNANegative Net Change OVIDNegative Net Change BNTXNegative Net Change
biofuels medical
Alexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On Track
by Zacks Equity Research
Alexion (ALXN) tops earnings and sales in the first quarter of 2021. Its merger with AstraZeneca is expected to close in the third quarter.
ALXNPositive Net Change AZNNegative Net Change RGENNegative Net Change NBRVPositive Net Change
biofuels earnings pharmaceuticals
What Awaits Renewable Energy Group (REGI) in Q1 Earnings?
by Zacks Equity Research
Renewable Energy's (REGI) Q1 results are expected to reflect rising biodiesel demand. However, higher feedstock costs might have hurt earnings.
CVXPositive Net Change AMRCPositive Net Change REGINegative Net Change DNOWNegative Net Change
biofuels earnings
5 Niche ETFs Dominating the Current Market Rally
by Sweta Killa
We have highlighted five ETFs from different zones that were at the heart of the latest market rally over the past week and will likely to do so if the current trends prevail.
COPXNegative Net Change SGDJPositive Net Change LITNegative Net Change REMXNegative Net Change
basic-materials biofuels etfs
What Awaits Renewable Energy Group (REGI) in Q4 Earnings?
by Zacks Equity Research
Renewable Energy Group's (REGI) Q4 results are expected to reflect signs of improved biodiesel and renewable diesel demand.
ECNegative Net Change REGINegative Net Change CEQPNegative Net Change FLMNPositive Net Change
biofuels earnings
Bear of the Day: CRISPR Therapeutics (CRSP)
by Kevin Cook
Gene editors got a big boost recently from sickle cell potential and Cathie Wood's thematic investing
CRSPNegative Net Change EDITNegative Net Change ARKKNegative Net Change NTLANegative Net Change ARKGNegative Net Change
biofuels cancer genetics genomics medical
Why Eastman Chemical (EMN) Might Surprise This Earnings Season
by Zacks Equity Research
Eastman Chemical (EMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
EMNNegative Net Change
biofuels earnings
5 ESG Stocks to Make the Most of the Bull Run in 2021
by Tirthankar Chakraborty
EV companies, alternative energy players and firms involved in hydrogen power generation are projected to gain in 2021. Notable among these are Tesla (TSLA) and FuelCell Energy (FCEL).
AESNo Net Change GMPositive Net Change TSLANegative Net Change FCELNegative Net Change ENPHNegative Net Change
alt-energy biofuels transportation
Top Ranked Value Stocks to Buy for November 13th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, November 13th
WMCPositive Net Change UNFIPositive Net Change GPPPositive Net Change
biofuels consumer-staples finance
Trevena (TRVN) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Trevena (TRVN) will provide updates on its newly launched drug and other pipeline products when it releases its third-quarter 2020 results.
ALKSPositive Net Change ALXNPositive Net Change ALNYNegative Net Change TRVNNegative Net Change
biofuels
Bear Of The Day: Nikola (NKLA)
by Daniel Laboe
Nikola (NKLA) bulls have gotten their face ripped clean off this week with the start-up's survival being put into question
SPCENegative Net Change NKLANegative Net Change DKNGPositive Net Change BPNegative Net Change
aerospace alt-energy auto-tires-trucks biofuels tech-stocks transportation
Pacific Ethanol's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Pacific Ethanol.
PEIXPositive Net Change
biofuels
Beat the Fed Minutes Blues With These ETF Areas
by Sweta Jaiswal, FRM
Let's look at some ETF areas that might continue being prudent investing options at a time when the Fed seems worried about the impact of the coronavirus outbreak on the U.S. economy.
IBBNegative Net Change XBINegative Net Change ARKWPositive Net Change BOTZNo Net Change ROBONegative Net Change FDNPositive Net Change SKYYPositive Net Change ESGUNegative Net Change ROBTNegative Net Change CLOUPositive Net Change USSGNegative Net Change
biofuels cloud-computing cybersecurity e-commerce etfs internet internet-content
Axsome's (AXSM) Earnings Beat in Q2, Pipeline Progresses
by Zacks Equity Research
Axsome (AXSM) incurs a narrower loss in the second quarter of 2020. The company remains on track to submit the NDA for AXS-05 and AXS-07.
EBSNegative Net Change HZNPPositive Net Change PCRXNegative Net Change AXSMPositive Net Change
biofuels earnings
Should You Buy CF Industries (CF) Ahead of Earnings?
by Zacks Equity Research
CF Industries (CF) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
CFNegative Net Change
biofuels earnings
Ultragenyx (RARE) Loss Narrows Y/Y & Revenues Beat Estimates
by Zacks Equity Research
Ultragenyx (RARE) reports a narrower-than-expected loss in the second quarter of 2020 and beats sales estimates.
BMRNNegative Net Change EBSNegative Net Change RARENegative Net Change APLTNegative Net Change
biofuels
Blueprint Medicines' (BPMC) Q2 Earnings Miss, Revenues Beat
by Zacks Equity Research
Blueprint Medicines (BPMC) posts a wider-than-expected loss but revenues beat estimates in the second quarter of 2020.
RHHBYNegative Net Change BMRNNegative Net Change EBSNegative Net Change BPMCPositive Net Change
biofuels
Late-Stage Coronavirus Vaccine Trials Begin: Biotech ETFs to Gain
by Sweta Jaiswal, FRM
Two major vaccine developers' entrance into the final stage trials is expected to boost investor optimism.
JNJNegative Net Change AZNNegative Net Change PFENegative Net Change MRNANegative Net Change NVAXPositive Net Change IBBNegative Net Change XBINegative Net Change BBHNegative Net Change FBTNegative Net Change ARKGNegative Net Change
biofuels etfs